Vitamin D3 for Life

Live Enlightened

Article

Vitamin D Transport and Tissue Delivery: Evidence Synthesis

Previous related pageVitamin D Levels, Biomarker Status and Biological Effect: Evidence SynthesisNext related pageWhat Circulating Vitamin D Levels Measure: Biomarker Status Versus Biological Effect: Full Study
Study at a glance

How do cells obtain vitamin D carried in blood?

Cells can access forms of vitamin D in different ways. One way is to take in forms that are not attached to proteins. Some cells can also take in vitamin D attached to a carrier protein. The available routes vary between tissues.

How do the kidneys recover vitamin D attached to a protein?

Specialised proteins on kidney cells help retrieve vitamin D together with its carrier protein from filtered fluid. Disrupting this system can cause forms of vitamin D to be lost in urine.

Does a blood vitamin D level show how much every tissue receives?

No. Delivery also depends on how cells in each tissue take in and process vitamin D. Studies of kidney, breast-derived cells, muscle cells and placental tissue show different parts of this system, but they do not establish one rule for how all organs take in vitamin D.

Read the full article below ↓

Transport in blood is only the first half of delivery

Carrier binding determines how vitamin D metabolites circulate, but tissue delivery asks a different question: how does material leave that circulating reservoir and become available to a particular cell? A simple answer based only on total plasma concentration is inadequate. So is a universal rule based only on the unbound fraction.

For many steroid-like molecules, the free-versus-total vitamin D distinction provides an important starting point: unbound ligand can cross membranes more readily, while strong protein binding limits the immediately free concentration. Vitamin D physiology, however, contains well-established exceptions in which cells retrieve carrier-bound substrate through receptor-mediated uptake. The consequence is a tissue-specific delivery system rather than one universal access rule.

The kidney provides the clearest causal model

The renal proximal tubule is the strongest demonstration that DBP-bound 25-hydroxyvitamin D is not simply an inaccessible circulating reserve. DBP and its bound metabolite pass through glomerular filtration and are retrieved by the endocytic receptors cubilin and megalin. Experimental disruption of this pathway produces urinary loss of vitamin-D-binding protein and 25-hydroxyvitamin D, lower circulating vitamin D metabolites and disturbed vitamin D metabolism.

This is more than a binding observation. It establishes a physiological conservation mechanism: the kidney can reclaim a protein-bound vitamin D metabolite from tubular fluid and deliver it into proximal-tubule cells, preserving substrate that would otherwise be lost in urine.

Carrier-bound substrate can be accessible outside the kidney

Extra-renal studies show that the renal model is not the only possible route. A deeper treatment of cellular uptake of vitamin D metabolites examines in more detail the mechanisms by which carrier-bound substrate can become biologically useful. Human mammary-derived cells express megalin and cubilin, internalize DBP and show reduced 25-hydroxyvitamin-D-driven responses when endocytosis is inhibited. This supports a mechanism in which local cellular vitamin D metabolism can depend partly on receptor-mediated access to DBP-bound precursor.

Skeletal-muscle experiments likewise demonstrate uptake and retention of 25-hydroxyvitamin D in differentiated muscle cells together with DBP uptake and megalin-associated effects. These findings support the possibility of an extravascular retention pool. They do not establish that skeletal muscle is quantitatively the dominant human storage organ for 25-hydroxyvitamin D.

The placenta shows another specialised delivery environment

Human placental perfusion and explant studies provide a different physiological setting. Vitamin D and placental function provides the organ-specific context for this specialised interface. Placental tissue takes up 25-hydroxyvitamin D, metabolises it and regulates its movement within the fetoplacental unit. Endocytic inhibition changes uptake and downstream handling, supporting active cellular control rather than simple passive equilibration across the maternal-fetal interface.

The placenta is a specialised organ, so its behaviour cannot be projected onto every tissue. Its importance for the broader transport question is conceptual: tissue exposure can depend on local uptake machinery and metabolism as well as on the concentration measured in plasma.

Why neither extreme model is sufficient

The evidence therefore argues against two opposite simplifications. It is too strong to say that only freely circulating vitamin D metabolites can reach cells, because receptor-mediated uptake of carrier-bound substrate is causally established in the kidney and supported in selected extra-renal systems. It is equally too strong to say that megalin/cubilin-mediated uptake is the general mechanism for all tissues.

Tissue delivery is conditional. It depends on the circulating carrier-bound and free pools, the metabolite involved, local receptor expression, cell differentiation and tissue-specific metabolic machinery. DBP can simultaneously restrict the instantaneous free fraction, preserve a large circulating reservoir and provide bound substrate to cells equipped to retrieve it. Total concentration, free concentration and tissue exposure are therefore related measurements or states, but they are not interchangeable descriptions of vitamin D availability.

Primary evidence and publication details

Safadi FF et al. Osteopathy and resistance to vitamin D toxicity in mice null for vitamin D binding protein. J Clin Invest. 1999;103:239-251.

Nykjaer A et al. Cubilin dysfunction causes abnormal metabolism of the steroid hormone 25(OH) vitamin D3. Proc Natl Acad Sci USA. 2001;98:13895-13900.

Rowling MJ, Kemmis CM, Taffany DA, Welsh J. Megalin-Mediated Endocytosis of Vitamin D Binding Protein Correlates with 25-Hydroxycholecalciferol Actions in Human Mammary Cells. J Nutr. 2006;136:2754-2759.

Abboud M et al. Evidence for a Specific Uptake and Retention Mechanism for 25-Hydroxyvitamin D (25OHD) in Skeletal Muscle Cells. Endocrinology. 2013;154:3022-3030.

Ashley B et al. Placental uptake and metabolism of 25(OH)vitamin D determine its activity within the fetoplacental unit. eLife. 2022;11:e71094.

Related reading

Physiology

Vitamin D Transport Proteins

Explore how vitamin D transport proteins regulate circulation, buffering, tissue delivery, and availability, shaping cellular metabolism and system-level vitamin D physiology.

Read more →

Original sources